BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

From Capacity to Capability: The New Race to Lead ASEAN Biomanufacturing

ASEAN is entering a new phase of biopharmaceutical manufacturing, where simply building more capacity will no longer guarantee competitiveness. As ...

July 16, 2026 | Expert Insight

Septa Pharmaceuticals Acquires CeeNU from Bristol Myers Squibb Canada

Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare sector, is proud to announce the successful acquisition of CeeNU...

July 17, 2026 | News

Metabolon Expands Microbiome Panel to Screen Over 800 Metabolites

Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health,...

July 17, 2026 | News

Evonik and evitria Simplify CHO-Based Protein Production with Ready-to-Use Expression Kit

New ready-to-use protein expression kit now available eviCHO Expression Kit simplifies transient protein expression workflows and enables faster, ...

July 17, 2026 | News

Insilico Medicine, Bora Pharmaceuticals Forge $2.5B Alliance to Build AI-Driven Drug Innovation Model

Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generat...

July 16, 2026 | News

Q32 Bio Reports Positive Phase 2a Results for Bempikibart in Severe Alopecia Areata, Plans Pivotal Programme

-- Clinically meaningful efficacy data on the primary endpoint was observed with a mean percent reduction in SALT score from baseline o...

July 15, 2026 | News

BioArctic and Eisai Secure FDA Approval for At-Home Leqembi Injection to Treat Early Alzheimer's Disease

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced that the US Food and Drug Administration (FDA) has approved a supplement...

July 15, 2026 | News

Mindbeam AI Unveils Generative AI Breakthrough for Safer Next-Generation Pain Therapies

Mindbeam AI, the company focused on next-generation AI infrastructure, announced a new research breakthrough showing how generative AI can accelerate...

July 13, 2026 | News

ACHP Launches Patient Advisory Council to Put Chronic Disease Voices at the Heart of Research

The Alliance of Community Health Plans (ACHP) is amplifying patients' voices on chronic disease research via its newly launched Patient Advisory Council. T...

July 13, 2026 | News

Lynk Pharmaceuticals Doses First Patient in Phase II Trial of Novel Vitiligo Therapy

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, ...

July 10, 2026 | News

India's Garware Fulflex Acquires U.S. Medical Manufacturing Facility to Accelerate Global Expansion

Garware Fulflex today announced the successful completion of its acquisition of a 300,000-square-foot, fully automated medical products manufacturing facil...

July 10, 2026 | News

Abcam and EpiCypher Partner to Advance High-Confidence Epigenomics Research

Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC...

July 10, 2026 | News

APAC's Peptide-Capacity Gamble

For most of pharmaceutical history, the hard part was finding a molecule that worked. The GLP-1 class inverted that logic. The science arrived first &mdash...

July 09, 2026 | Analysis

Insilico Medicine Advances AI-Discovered IPF Drug Rentosertib into Phase III Trial

Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-...

July 09, 2026 | News

Stay Connected